Crinetics Pharmaceuticals In – Investors and Politicians Who Own It
No ticker
Investors who own it
3 tracked investors, $470.1M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Farallon Capital ManagementQ2 2026 | $336.4M | 1.55% |
Julian i Felix BakerBaker Bros. Advisors, Q2 2026 | $88M | 0.44% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $45.7M | 2.09% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Farallon Capital Management | Added +251% | 4,075,098 |
| Joseph Edelman | Reduced −75% | 184,525 |
| Stanley Druckenmiller | Reduced −60% | 122,700 |
| Julian i Felix Baker | Sold out | 0 |
| Daniel Schneeberger | Reduced −40% | 53,125 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.